AmCad BioMed Corporation 4188.TWO Stock
AmCad BioMed Corporation Price Chart
AmCad BioMed Corporation 4188.TWO Financial and Trading Overview
| AmCad BioMed Corporation stock price | 26.95 TWD |
| Previous Close | 16.55 TWD |
| Open | 16.55 TWD |
| Bid | 16.55 TWD x 0 |
| Ask | 16.7 TWD x 0 |
| Day's Range | 16.55 - 16.8 TWD |
| 52 Week Range | 14.2 - 19.15 TWD |
| Volume | 55K TWD |
| Avg. Volume | 78.57K TWD |
| Market Cap | 880.81M TWD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.85 TWD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
4188.TWO Valuation Measures
| Enterprise Value | 880.81M TWD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 2.0744545 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
AmCad BioMed Corporation Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 0.30% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 19.15 TWD |
| 52 Week Low | 14.2 TWD |
| 50-Day Moving Average | 16.39 TWD |
| 200-Day Moving Average | 16.19 TWD |
4188.TWO Share Statistics
| Avg. Volume (3 month) | 78.57K TWD |
| Avg. Daily Volume (10-Days) | 265.1K TWD |
| Shares Outstanding | 53.22M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 54.04% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | 1.16 TWD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 38.05M TWD |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -1.05 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | 7.978 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of AmCad BioMed Corporation
| Country | Taiwan |
| State | N/A |
| City | Taipei |
| Address | No. 167 Fuxing North Road |
| ZIP | 104 |
| Phone | 886 2 2713 6227 |
| Website | https://www.amcad.com.tw |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
AmCad BioMed Corporation develops computer-aided detection and diagnosis (CAD) software devices primarily in Taiwan. It offers products for early detection and diagnosis of various diseases, such as thyroid cancers, fatty liver, liver fibrosis, and obstructive sleep apnea. The company's products include AmCAD-UT Detection, a CAD device for ultrasound images of thyroid nodules; and AmCAD-UO for detection of obstructive sleep apnea on awake patients. It also developing AmCAD-CA, a software device for analyzing digital cytological images; AmCAD-US, a software device for visualizing and quantifying statistical distributions of backscattered signals echoed by tissue compositions in the body from FDA-cleared ultrasound systems; and AmCAD-UV, a software device for quantifying and classifying the ultrasonic color intensity data acquired from FDA-cleared ultrasound systems and displaying the noise-reduced color-coded pulsatile signals. The company was incorporated in 2008 and is based in Taipei City, Taiwan.
Q&A For AmCad BioMed Corporation Stock
What is a current 4188.TWO stock price?
AmCad BioMed Corporation 4188.TWO stock price today per share is 26.95 TWD.
How to purchase AmCad BioMed Corporation stock?
You can buy 4188.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for AmCad BioMed Corporation?
The stock symbol or ticker of AmCad BioMed Corporation is 4188.TWO.
Which industry does the AmCad BioMed Corporation company belong to?
The AmCad BioMed Corporation industry is Medical Devices.
How many shares does AmCad BioMed Corporation have in circulation?
The max supply of AmCad BioMed Corporation shares is 53.3M.
What is AmCad BioMed Corporation Price to Earnings Ratio (PE Ratio)?
AmCad BioMed Corporation PE Ratio is now.
What was AmCad BioMed Corporation earnings per share over the trailing 12 months (TTM)?
AmCad BioMed Corporation EPS is -0.85 TWD over the trailing 12 months.
Which sector does the AmCad BioMed Corporation company belong to?
The AmCad BioMed Corporation sector is Healthcare.